Roche reported positive five-year effectiveness, safety, and durability data for Susvimo (ranibizumab injection) for the treatment of neovascular or "wet" age-related macular degeneration (nAMD) from the Phase III Portal study, a long-term extension
.png "Cadila Unveils Vasograin Plus for Fast, Dual-Action Migraine Relief")
In a major leap forward for migraine treatment, Cadila Pharmaceuticals has launched Vasograin Plus, a powerful dual-action therapy for the acute treatment of migraine, with or without aura, in adults and adolescents.This cutting-edge...
AbbVie announced that it has submitted a supplemental New Drug Application to the U.S. FDA for a new fixed-duration, all-oral combination therapy with Venclexta and acalabrutinib for the treatment of previously untreated chronic lymphocytic...
The National Award for Emerging State in Organ Donation has been awarded to Odisha in recognition of its growing leadership and significant development in organ transplantation and public health education.
According to Orchid Pharma, the Court of France has issued an order in favor of the company, allowing it to purchase Allecra Therapeutics SAS's assets as of August 1, 2025.
.JPG "ASPA Shares Anti-Counterfeit Insights at ASIA Security 2025")
The Authentication Solution Providers’ Association (ASPA), the leading industry body dedicated to anti-counterfeiting and traceability, presented a thought leadership paper
STEER World, a global leader in materials transformation technology, today announced through its Lifesciences arm, STEERLife, a novel platform for advanced ingredient solutions.
Gujarat Chief Minister, Bhupendra Patel, opened the 20th edition of Pharma & Labtech Expo 2025 at the Helipad Exhibition Centre in Gandhinagar with State Health Minister Rishikesh Patel.
As part of a recent examination, the regulator Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), directed Akum Pharmaceuticals to submit supportive safety data
Intas Pharmaceuticals, a prominent multinational company specializing in pharmaceutical formulation development, manufacturing, and marketing, has introduced Hetronifly (serplulimab) in the Indian market. This product is the first PD-1 inhibitor to
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")